Jubilant Pharmova Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code:	530019	NSE Symbol:	JUBLPHARMA	P/E :	0
ISIN Demat:	INE700A01033	Div & Yield %:	0.49	EPS :	1.98
Book Value:	145.16	Market Cap (Rs. Cr.):	16,329.84	Face Value :	1

Date	Headline
05-Aug-26	Jubilant Pharmova delays board meeting to August 10 to review quarterly financial results
01-Aug-26	Jubilant Pharmova receives assurance for BRSR reporting following TÜV SÜD assessment
30-Jul-26	Jubilant Pharmova to review quarterly financial results at a board meeting Friday
19-Jun-26	USFDA inspects Jubilant HollisterStier LLC's contract manufacturing unit located at Spokane
22-May-26	Board of Jubilant Pharmova recommends final dividend
25-Apr-26	Jubilant Pharmova to convene board meeting
23-Jan-26	Jubilant Pharmova to declare Quarterly Results
02-Dec-25	Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc.
31-Oct-25	Board of Jubilant Pharmova approves grant of 1,506 stock options
15-Oct-25	Jubilant Pharmova to discuss results

Company Snapshot